Prevalence of Pain and Use of Prescription Opioids Among Older Adults: Results from the Brazilian Longitudinal Study of Aging (ELSI-Brazil)

Overview

Journal Lancet Reg Health Am

Date 2023 Mar 13

PMID 36908501

Authors

Pricila H Mullachery

Maria Fernanda Lima-Costa

Antonio Ignacio de Loyola Filho

Affiliations

Soon will be listed here.

Abstract

Background: Pain has a significant impact on people's quality of life. The use of prescription opioids to treat pain is associated with an increased risk of opioid use disorders and overdose death. We measured the prevalence of recurrent pain, prescription opioid use, and associations between chronic conditions and prescription opioid use among Brazilian older adults.

Methods: We used data from the first population-based longitudinal study of aging in Brazil (ELSI-Brazil), 2019-2020 (mean age = 63.3; 54.4% female). Outcomes were: (1) experience of recurrent pain and (2) use of opioid analgesics in the past three months among those who experience pain. Exposures included selected health conditions, history of falls, and hospitalizations.

Findings: Prevalence of pain (n = 9234) was 36.9% (95% CI: 32.6-41.1). Pain was reported more frequently by female participants, low-income individuals, and those with a previous diagnosis of arthritis, chronic back pain, depressive symptoms, history of falls, and hospitalizations. Prevalence of opioid use among those reporting pain (n = 3350) was 30% (95% CI: 23.1-38.0). Prevalence of opioid use was higher among female and single individuals. In adjusted models, arthritis, chronic back pain, and presence of depressive symptoms were associated with prescription opioid use.

Interpretation: Prescription opioid use was reported by a sizable portion of the older adults who suffer from pain in Brazil. In a context of growing consumption of prescription opioids, opioid misuse has the potential to increase in the future. Surveillance of prescription opioid use is critical to prevent their harmful consequences.

Funding: ELSI-Brazil was funded by the Brazilian Ministry of Health.

Citing Articles

Observational evidence linking psychotropic medicines to the dispensing of opioid agents in later life.

Almeida O, Page A, Sanfilippo F, Preen D, Etherton-Beer C Psychogeriatrics. 2024; 24(3):665-674.

PMID: 38561326 PMC: 11578014. DOI: 10.1111/psyg.13123.

Conditioned morphine tolerance promotes neurogenesis, dendritic remodelling and pro-plasticity molecules in the adult rat hippocampus.

Nejad G, Mottarlini F, Tavassoli Z, Caffino L, Fumagalli F, Homberg J Addict Biol. 2024; 29(3):e13377.

PMID: 38506630 PMC: 11061850. DOI: 10.1111/adb.13377.

Shift in hospital opioid use during the COVID-19 pandemic in Brazil: a time-series analysis of one million prescriptions.

Carvalho R, de Magalhaes-Barbosa M, Bianchi L, Rodrigues-Santos G, da Cunha A, Bastos F Sci Rep. 2023; 13(1):17197.

PMID: 37821638 PMC: 10567754. DOI: 10.1038/s41598-023-44533-5.

Pain in older adults with dementia: improving diagnosis to provide better care.

Caramelli P Arq Neuropsiquiatr. 2023; 81(8):705-706.

PMID: 37647903 PMC: 10468231. DOI: 10.1055/s-0043-1772671.

References

van den Beuken-van Everdingen M, Hochstenbach L, Joosten E, Tjan-Heijnen V, Janssen D . Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis. J Pain Symptom Manage. 2016; 51(6):1070-1090.e9. DOI: 10.1016/j.jpainsymman.2015.12.340. View

Tsang A, Von Korff M, Lee S, Alonso J, Karam E, Angermeyer M . Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. J Pain. 2008; 9(10):883-91. DOI: 10.1016/j.jpain.2008.05.005. View

Atzeni F, Alciati A, Bazzichi L, Govoni M, Biasi G, Di Franco M . Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry. Clin Exp Rheumatol. 2022; 40(6):1183-1188. DOI: 10.55563/clinexprheumatol/64963d. View

Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T . The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014; 73(7):1316-22. DOI: 10.1136/annrheumdis-2013-204627. View

Macinko J, Mullachery P . Education-related health inequities in noncommunicable diseases: an analysis of the Brazilian National Health Survey, 2013 and 2019. Cad Saude Publica. 2022; 38Suppl 1(Suppl 1):e00137721. DOI: 10.1590/0102-311X00137721. View

Kehlet H, Jensen T, Woolf C . Persistent postsurgical pain: risk factors and prevention. Lancet. 2006; 367(9522):1618-25. DOI: 10.1016/S0140-6736(06)68700-X. View

Humphreys K . Avoiding globalisation of the prescription opioid epidemic. Lancet. 2017; 390(10093):437-439. DOI: 10.1016/S0140-6736(17)31918-9. View

Knaul F, Farmer P, Krakauer E, De Lima L, Bhadelia A, Kwete X . Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report. Lancet. 2017; 391(10128):1391-1454. DOI: 10.1016/S0140-6736(17)32513-8. View

Maia L, Daldegan-Bueno D, Fischer B . Opioid use, regulation, and harms in Brazil: a comprehensive narrative overview of available data and indicators. Subst Abuse Treat Prev Policy. 2021; 16(1):12. PMC: 7836143. DOI: 10.1186/s13011-021-00348-z. View

10.

Bair M, Robinson R, Katon W, Kroenke K . Depression and pain comorbidity: a literature review. Arch Intern Med. 2003; 163(20):2433-45. DOI: 10.1001/archinte.163.20.2433. View

11.

Jackson T, Thomas S, Stabile V, Shotwell M, Han X, McQueen K . A Systematic Review and Meta-Analysis of the Global Burden of Chronic Pain Without Clear Etiology in Low- and Middle-Income Countries: Trends in Heterogeneous Data and a Proposal for New Assessment Methods. Anesth Analg. 2016; 123(3):739-48. DOI: 10.1213/ANE.0000000000001389. View

12.

Cohen S, Vase L, Hooten W . Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021; 397(10289):2082-2097. DOI: 10.1016/S0140-6736(21)00393-7. View

13.

Shmagel A, Ngo L, Ensrud K, Foley R . Prescription Medication Use Among Community-Based U.S. Adults With Chronic Low Back Pain: A Cross-Sectional Population Based Study. J Pain. 2018; 19(10):1104-1112. PMC: 6163076. DOI: 10.1016/j.jpain.2018.04.004. View

14.

Toblin R, Mack K, Perveen G, Paulozzi L . A population-based survey of chronic pain and its treatment with prescription drugs. Pain. 2011; 152(6):1249-1255. DOI: 10.1016/j.pain.2010.12.036. View

15.

Driscoll T, Jacklyn G, Orchard J, Passmore E, Vos T, Freedman G . The global burden of occupationally related low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014; 73(6):975-81. DOI: 10.1136/annrheumdis-2013-204631. View

16.

Hadland S, Cerda M, Li Y, Krieger M, Marshall B . Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing. JAMA Intern Med. 2018; 178(6):861-863. PMC: 6145750. DOI: 10.1001/jamainternmed.2018.1999. View

17.

Krawczyk N, Do Nascimento Silva P, De Boni R, Mota J, Vascncellos M, Bertoni N . Non-medical use of opioid analgesics in contemporary Brazil: Findings from the 2015 Brazilian National Household Survey on Substance Use. Glob Public Health. 2019; 15(2):299-306. PMC: 6908778. DOI: 10.1080/17441692.2019.1629610. View

18.

Hoy D, Bain C, Williams G, March L, Brooks P, Blyth F . A systematic review of the global prevalence of low back pain. Arthritis Rheum. 2012; 64(6):2028-37. DOI: 10.1002/art.34347. View

19.

Castillo-Carniglia A, Gonzalez-Santa Cruz A, Cerda M, Delcher C, Shev A, Wintemute G . Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California's prescription drug monitoring program. Drug Alcohol Depend. 2020; 218:108405. PMC: 7750250. DOI: 10.1016/j.drugalcdep.2020.108405. View

20.

Reid K, Harker J, Bala M, Truyers C, Kellen E, Bekkering G . Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact. Curr Med Res Opin. 2011; 27(2):449-62. DOI: 10.1185/03007995.2010.545813. View